IL235287A0 - Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders - Google Patents
Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disordersInfo
- Publication number
- IL235287A0 IL235287A0 IL235287A IL23528714A IL235287A0 IL 235287 A0 IL235287 A0 IL 235287A0 IL 235287 A IL235287 A IL 235287A IL 23528714 A IL23528714 A IL 23528714A IL 235287 A0 IL235287 A0 IL 235287A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- improved characteristics
- neuromuscular disorders
- modulating oligonucleotides
- rna modulating
- Prior art date
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261636914P | 2012-04-23 | 2012-04-23 | |
EP12165139 | 2012-04-23 | ||
PCT/NL2013/050306 WO2013162363A1 (en) | 2012-04-23 | 2013-04-23 | RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
IL235287A0 true IL235287A0 (en) | 2014-12-31 |
Family
ID=66624926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL235287A IL235287A0 (en) | 2012-04-23 | 2014-10-22 | Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders |
Country Status (3)
Country | Link |
---|---|
CY (1) | CY1121358T1 (en) |
HK (1) | HK1243733A1 (en) |
IL (1) | IL235287A0 (en) |
-
2014
- 2014-10-22 IL IL235287A patent/IL235287A0/en active IP Right Grant
-
2017
- 2017-08-03 CY CY20171100837T patent/CY1121358T1/en unknown
-
2018
- 2018-03-07 HK HK18103251.8A patent/HK1243733A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK1243733A1 (en) | 2018-07-20 |
CY1121358T1 (en) | 2020-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20171254T1 (en) | Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders | |
IL266159A (en) | Treatment of circadian rhythm disorders | |
HK1209456A1 (en) | Oligonucleotide for the treatment of muscular dystrophy patients | |
IL263661A (en) | Combination therapy for the treatment of glioblastoma | |
IL233714A0 (en) | Treatment of circadian rhythm disorders | |
EP2827856A4 (en) | Compounds and compositions for the treatment of muscular disorders | |
EP2819703A4 (en) | Pain treatment | |
LT2838539T (en) | Estrogenic derivatives for use in the treatment of neurological disorders. | |
HK1215173A1 (en) | Methods of treating s. aureus-associated diseases | |
EP2720708A4 (en) | Targeting the neuromuscular junction for treatment | |
HK1201878A1 (en) | Oligonucleotides for modulating gene expression and uses thereof | |
HK1203054A1 (en) | Dinuceloside polyphosphates for the treatment of pain | |
ZA201408060B (en) | Compositions and methods for the treatment of neurological disorders | |
ZA201408061B (en) | Compositions and methods for the treatment of neurological disorders | |
HK1243733A1 (en) | Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders | |
EP2846796A4 (en) | Methods of maintaining, treating or improving cognitive function | |
HK1214293A1 (en) | C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders c-myc | |
AU2012900796A0 (en) | Pain treatment | |
GB201212604D0 (en) | New treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |